Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jinhwa

Jinhwa Chung, Bucheon KR

Patent application numberDescriptionPublished
20100327758LED Light Emitting Device And Driving Method Thereof - The present invention relates to an LED light emitting device and a driving method, and discloses a technology that may improve a slew rate of a channel current flowing through an LED channel when driving with a pulse width modulation method. For this, the present invention includes an LED channel consisting of a plurality of LED elements that are consecutively and serially connected, a current control switch that is connected to the end of the LED channel and performs a switching operation, and an operational amplifier that controls the switching operation of the current control switch according to a pulse width modulation signal. The LED driver samples an output voltage at the operational amplifier when the pulse width modulation signal is in an on state, and maintains the output voltage of the operational amplifier when the pulse width modulation signal is in an off state.12-30-2010

Jinhwa Chung, Seoul KR

Patent application numberDescriptionPublished
20120032611LED EMITTING DEVICE AND DRIVING METHOD THEREOF - The present invention relates to an LED emitting device and a driving method thereof including at least two LED channels.02-09-2012

Jinhwa Lee, Yongin-Si KR

Patent application numberDescriptionPublished
20080207704HETEROARYL-IMIDAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS - A heteroaryl-imidazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB08-28-2008
20080207705Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor Antagonists - A novel heteroaryl-imidazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB08-28-2008
20080262066Azole Derivatives as Cannabinoid CB1 Receptor Antagonists - A novel azole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB10-23-2008
20100113500ORALLY BIOAVAILABLE PRODUCTS OF (+)-3-HYDROXYMORPHINAN FOR PARKINSON'S DISEASE PREVENTION OR TREATMENT - The present invention is directed to a novel prodrug of (+)-3-hydroxymorphinan compound of formula (I) or a pharmaceutically acceptable salt thereof, a method for preparing the same, and its use for preventing or treating Parkinson's disease.05-06-2010
20110178091ARYLPIPERAZINE-CONTAINING PYRROLE 3-CARBOXAMIDE DERIVATIVES FOR TREATING DEPRESSIVE DISORDERS - The present invention relates to novel arylpiperazine-containing pyrrole 3-carboxamide derivatives of formula (I) or a pharmaceutically acceptable salt thereof which is useful for preventing or treating depressive disorders. The present invention also provides a method for preparing the arylpiperazine-containing pyrrole 3-carboxamide derivatives or the pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and a method for preventing or treating depressive disorders.07-21-2011
20110178140SULFUR CONTAINING PYRAZOLE-HETEROCYCLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS - A novel sulfur containing heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB07-21-2011

Patent applications by Jinhwa Lee, Yongin-Si KR